Acadian Asset Management LLC Kymera Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$31.08 - $51.95 $93,364 - $156,057	-3,004 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$35.64 - $85.46 $70,389 - $168,783	-1,975 Reduced 39.67%	3,004 $117,000
Q4 2020 Feb 11, 2021	BUY	$28.07 - $87.83 $139,760 - $437,305	4,979 New	4,979 $309,000

160

63.1M

22.6K

14.4K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.46B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.